blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2643344

EP2643344 - HUMAN LACTOFERRIN DERIVED PEPTIDE FOR USE AS AN ANTIGEN MASKING AGENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.01.2018
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  17.02.2017
FormerGrant of patent is intended
Status updated on  06.02.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Evonik Röhm GmbH
Kirschenallee 45
64293 Darmstadt / DE
[2013/40]
Inventor(s)01 / HARTWIG, Benedikt
Schwarzer Weg 28
64287 Darmstadt / DE
02 / TOME ALCALDE, Juan
Calle Quintana 9 Piso 7
Puerta 5
28008 Madrid / ES
03 / WINDHAB, Norbert
Ubierstraße 20
65719 Hofheim / DE
04 / ANSUATEGUI PANZANO, María del Pilar
Calle Fernán González 13
7 izquierda
28009 Madrid / ES
05 / VARA CARRERA, Matías Javier
Calle Rafael Moneo 28
45200 Illescas Toledo / ES
 [2017/12]
Former [2013/40]01 / HARTWIG, Benedikt
Schwarzer Weg 28
64287 Darmstadt / DE
02 / TOME ALCALDE, Juan
Calle Quintana 9 Piso 7
Puerta 5
E-28008 Madrid / ES
03 / WINDHAB, Norbert
Ubierstraße 20
65719 Hofheim / DE
04 / ANSUATEGUI PANZANO, María del Pilar
Calle Fernán González 13
7 izquierda
E-28009 Madrid / ES
05 / VARA CARRERA, Matías Javier
Calle Rafael Moneo 28
E-45200 Illescas Toledo / ES
Application number, filing date10784307.026.11.2010
[2017/12]
WO2010EP68302
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012069089
Date:31.05.2012
Language:EN
[2012/22]
Type: A1 Application with search report 
No.:EP2643344
Date:02.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 31.05.2012 takes the place of the publication of the European patent application.
[2013/40]
Type: B1 Patent specification 
No.:EP2643344
Date:22.03.2017
Language:EN
[2017/12]
Search report(s)International search report - published on:EP31.05.2012
ClassificationIPC:C07K14/435, C07K14/00
[2013/40]
CPC:
C07K14/79 (EP,CN,KR,US); A61K47/42 (CN,KR,US); A61K38/1703 (KR);
A61K47/644 (EP,CN,US); A61K47/6811 (US); A61P37/06 (EP);
A61P37/08 (EP); A61K38/00 (EP,CN,US); A61K38/16 (EP,US);
A61K38/40 (EP,US); C07K14/435 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/40]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PEPTIDE BASIEREND AUF DER MENSCHLICHEN LACTOFERRINSEQUENZ UND IHRE VERWENDUNG ALS ANTIGENMASKIERUNGSMITTEL[2016/41]
English:HUMAN LACTOFERRIN DERIVED PEPTIDE FOR USE AS AN ANTIGEN MASKING AGENT[2013/40]
French:PEPTIDES BASÉES SUR LA SÉQUENCE DE LACTOFERRIN HUMAIN ET LEUR UTILISATION COMME AGENT DE MASQUAGE D'UN ANTIGÈNE[2016/47]
Former [2013/40]PEPTID AUS MENSCHLICHEM LACTOFERRIN ALS ANTIGENMASKIERUNGSSTOFF
Former [2013/40]PEPTIDE DÉRIVÉ DE LA LACTOFERRINE HUMAINE DESTINÉ À ÊTRE UTILISÉ EN TANT QU'AGENT DE MASQUAGE ANTIGÉNIQUE
Entry into regional phase03.05.2013National basic fee paid 
03.05.2013Designation fee(s) paid 
03.05.2013Examination fee paid 
Examination procedure03.05.2013Examination requested  [2013/40]
25.11.2013Amendment by applicant (claims and/or description)
25.06.2014Despatch of a communication from the examining division (Time limit: M04)
21.10.2014Reply to a communication from the examining division
30.01.2015Despatch of a communication from the examining division (Time limit: M04)
12.05.2015Reply to a communication from the examining division
14.04.2016Despatch of a communication from the examining division (Time limit: M02)
01.06.2016Reply to a communication from the examining division
25.10.2016Communication of intention to grant the patent
06.02.2017Fee for grant paid
06.02.2017Fee for publishing/printing paid
06.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.06.2014
Opposition(s)02.01.2018No opposition filed within time limit [2018/09]
Fees paidRenewal fee
03.05.2013Renewal fee patent year 03
28.11.2013Renewal fee patent year 04
25.11.2014Renewal fee patent year 05
24.11.2015Renewal fee patent year 06
23.11.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
LU26.11.2017
MT26.11.2017
[2020/34]
Former [2019/51]CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
LU26.11.2017
MT26.11.2017
Former [2019/46]CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
LU26.11.2017
MT26.11.2017
Former [2018/43]CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
LU26.11.2017
MT26.11.2017
Former [2018/41]CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
LU26.11.2017
Former [2018/33]CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/09]CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/51]CZ22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/49]CZ22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
RO22.03.2017
RS22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
IS22.07.2017
Former [2017/48]CZ22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
RS22.03.2017
BG22.06.2017
NO22.06.2017
Former [2017/41]FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
RS22.03.2017
BG22.06.2017
NO22.06.2017
Cited inInternational search[X]WO2004052305  (AGENNIX INC [US], et al) [X] 1,11* [0011], [0104],[0087] and claims *;
 [X]WO2007048599  (DEGUSSA [DE], et al) [X] 11 * the whole document *;
 [X]WO2007076904  (UNIV EBERHARD KARLS [DE], et al) [X] 11 * Pages 8 and 19 and claims 18-19 *;
    [ ] - "Human/bovine lactoferrin peptide SEQ ID NO:3.", Geneseq, (20070906), Database accession no. AGE17535, URL: EBI [ ] * compound . *
 [A]  - TOMITA M ET AL, "Twenty-five years of research on bovine lactoferrin applications", BIOCHIMIE, MASSON, PARIS, FR, vol. 91, no. 1, doi:DOI:10.1016/J.BIOCHI.2008.05.021, ISSN 0300-9084, (20090101), pages 52 - 57, (20080610), XP025869227 [A] 1-11 * Fig. 1 and 2 and item 2.4 *

DOI:   http://dx.doi.org/10.1016/j.biochi.2008.05.021
by applicantWO2007048599
 WO2007076904
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.